umeclidinium bromide/vilanterol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for umeclidinium bromide/vilanterol, covering 2014-05-29 to 2014-05-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]